Newman, R. G. (2007). Blick von aussen : Schweizerische Empfehlungen zu substitutionsgestützten Behandlungen. Akzeptanzorientierte Drogenarbeit = Acceptance-oriented drug work, 4(20.09.2007), 12–18.
Keywords: treatment and maintenance; drug substitution therapy; methadone maintenance; government and politics; laws and regulations; public opinion; United States; Germany; Switzerland; conference
|
Mann, R. (2004). Substitution und Fahrerlaubnis – Nachweis der Kraftfahreignung gemäss Fahrerlaubnis-Verordnung ( FeV ). Akzeptanzorientierte Drogenarbeit = Acceptance-oriented drug work, 1(01.12.2004), 10–11.
Keywords: treatment and maintenance; drug substitution therapy; methadone maintenance; buprenorphine; AOD use and driving; specific AODU measurement and test; laws and regulations; Germany
|
Hölzmann, C. (2004). Ist Case Management/Motivational Interviewing (CM/MI) mit den Grundsätzen der akzeptanzorientierten Drogenarbeit vereinbar? : eine Diskussion zur Betreuungsmethode CM/MI im bundesdeutschen Modellprojekt zur heroingestützten Behandlung Opiatabhängiger. Akzeptanzorientierte Drogenarbeit = Acceptance-oriented drug work, 1(14.12.2004), 12–16.
Keywords: treatment and maintenance; heroin-assisted treatment; case management; Germany
|
Ebert, K., & Sturm, S. (2006). Alte Junkies : eine neue Herausforderung für die Drogenhilfe im Rahmen ambulant betreuten Wohnens? Akzeptanzorientierte Drogenarbeit = Acceptance-oriented drug work, 3(30.12.2006), 19–30.
Keywords: treatment and maintenance; inpatient care; supported accommodation; drug dependent; elderly; old age; Germany
|
Caplehorn, J. R. M., & Rubin, G. (2004). Injecting drug users' attitudes to needle-sharing, hepatitis C, HIV/AIDS and harm minimisation. Akzeptanzorientierte Drogenarbeit = Acceptance-oriented drug work, 1(29.12.2004), 29–34.
Abstract: Objective – To measure injecting drug user’s attitudes to allowing other persons to use a needle and syringe known to be contaminated with hepatitis C virus. Methods – Demographic and historical data were collected at interview from a convenience sample of methadone and buprenorphine maintenance patients in mid-2002. Respondents also answered 12 attitudinal items on needlesharing, hepatitis C, HIV/AIDS and harm minimisation. Results – Subjects generally understood the threat posed by HIV and hepatitis C virus including the risk of reinfection with hepatitis C. They supported needle and syringe exchanges (90%) and safe injecting rooms (84%) and a majority supported the decriminalization of cannabis (69%) and the prescription of heroin to addicts (61%). However, forty-one of 100 respondents either failed to reject the proposition that “Even if I had hepC, I’d let people use needles after me – I’d warn them but it’s their risk” or failed to accept the proposition “If I had hepC, I’d never let anyone use my needles after me, even if it meant they didn’t get a hit”. Conclusion – Despite an awareness of the risks involved, many Sydney injecting drug users are still prepared to let other people use a needle and syringe known to be contaminated with hepatitis C virus. Implications – Attempts should be made to reduce the supply of contaminated needles and syringes by encouraging injecting drug users to take responsibility for the health and safety of other users.
Keywords: social services; harm reduction; intravenous drug user; needle sharing; hepatitis C; HIV infection; Aids
|
Schmidt, R. (2009). Eingliederung und Teilhabe : der Hamburger Weg zur psychosozialen Betreuung Substituierter aus historischer Perspektive. Akzeptanzorientierte Drogenarbeit = Acceptance-oriented drug work, 6(20.01.2009), 1–5.
Keywords: treatment and maintenance; outpatient care; psychosocial treatment method; history; Germany; Hamburg
|
European Monitoring Centre for Drugs and Drug Addiction, & Inter-American Drug Abuse Control Commission of the Organization of American States. (2010). Building a national drugs observatory : a joint handbook. Joint publications. Luxembourg: Office for Official Publications of the European Communities.
Abstract: National drugs observatories have flourished and developed rapidly over the last two decades as a direct consequence of the decisions taken to establish regional drug monitoring systems, both in the European Union and in the Americas. Initially, there was no reference framework available — observatories were set-up using trial and error, taking into account different national contexts and resources. This explains why today there are as many models of observatories as there are countries establishing them. Looking back at this long process, there seemed to be a need to formalise the experiences in the field, and to identify some key concepts and principles that remain valid irrespective of country or region. This handbook, a joint production by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the Inter-American Drug Abuse Control Commission of the Organization of American States (CICAD–OAS), presents and describes in a clear and informative way the core operational processes and the key strategic factors that are common to all national drugs observatories.
Keywords: monitoring; drug; organizational structure; administration and management; Europe; Americas; international area
|
Observatoire européen des drogues et des toxicomanies, & Commission interaméricaine de lutte contre l'abus des drogues de l'Organisation des États américains (Eds.). (2010). Création d'un observatoire national des drogues : manuel conjoint. Joint publications. Luxembourg: Office des publications officielles des Communautés européennes.
Abstract: National drugs observatories have flourished and developed rapidly over the last two decades as a direct consequence of the decisions taken to establish regional drug monitoring systems, both in the European Union and in the Americas. Initially, there was no reference framework available — observatories were set-up using trial and error, taking into account different national contexts and resources. This explains why today there are as many models of observatories as there are countries establishing them. Looking back at this long process, there seemed to be a need to formalise the experiences in the field, and to identify some key concepts and principles that remain valid irrespective of country or region. This handbook, a joint production by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the Inter-American Drug Abuse Control Commission of the Organization of American States (CICAD–OAS), presents and describes in a clear and informative way the core operational processes and the key strategic factors that are common to all national drugs observatories.
Keywords: monitoring; drug; organizational structure; administration and management; Europe; Americas; international area
|
European Monitoring Centre for Drugs and Drug Addiction, & Europol. (2009). Methamphetamine : a European Union perspective in the global context. Luxembourg: Publications Office of the European Union.
Abstract: This publication is the first in a series dedicated to prevalent illicit synthetic stimulant drugs, also known as amphetamine-type stimulants (ATS). The ATS category is made up of two groups of substances. This study focuses on the supply and use of methamphetamine in Europe, set in a global context. Methamphetamine is probably the most widely consumed synthetic stimulant in the world. In many countries across the globe it is reportedly the second most prevalent illicit drug after cannabis.
Keywords: addiction; AOD dependence; chemical addiction; amphetamines; Europe
|
European Monitoring Centre for Drugs and Drug Addiction, & Europol. (2010). Cocaine : a European Union perspective in the global context. Luxembourg: Publications Office of the European Union.
Abstract: This report provides an overview of what is known about how cocaine is produced and trafficked into the European Union. It aims to provide a better understanding of the actors involved, the routes taken, and the scale of the problem in Europe. It also reviews some of the supply reduction responses already developed at European level. Its findings are based on the latest data and analysis available from specialised European and international organisations, NGOs and scholars. This publication is structured in a way that provides a condensed review of key issues relevant to understanding how cocaine reaches European markets. Background information on the chemistry and legal status of cocaine and crack cocaine, as well as key European figures, are also provided.
Keywords: addiction; AOD dependence; chemical addiction; cocaine; crack cocaine; illegal production of drugs; drug trafficking; drug market; international area; Europe
|